Q/C Technologies Inc. (QCLS)
NASDAQ: QCLSHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
QCLS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.40M
- P/E (TTM)
- 0.06
- EPS (TTM)
- $4.69
- Dividend yield
- None
- 52-week range
- 0.275 – 8.17
- Day range
- 0.275 – 0.3205
- Volume / Avg
- 126.00K / 5.05M
- Beta
- —
- Shares outstanding
- 8.62M
52-week range
QCLS stock today
On Nov 20, QCLS ended the session at $0.2784, shedding $0.0178 (6.01%), versus the S&P 500's 3.70% decline. Trading was light, with 126.00K shares changing hands, about 2% of the average daily volume. Shares are 96.6% below their 52-week high of $8.17 and 1.2% above the 52-week low of $0.275, near the bottom of the past year's range.
Q/C Technologies trades at 0.1x its trailing twelve-month earnings per share of $4.69.
Summary generated from market data by MetaCap's automated system. Methodology
About Q/C Technologies
Company profileQ/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments.
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Headquarters
- New York, NY
- Employees
- 3
- IPO year
- 2014
- Website
- qctechnologies.com
Financial highlights
Full financialsQ/C Technologies reported a net loss of $11.6 million, compared with a loss of $23.4 million a year earlier. Diluted earnings per share came in at -$8.66.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-11.63M | $-23.36M | $-4.00M | $-15.20M | $-29.89M |
| EPS (diluted) | $-8.66 | $-1,080.87 | $-5.33 | $-11.74 | — |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 18, 2026
- EPS actual vs est.
- $-0.14 vs —
QCLS news
All QCLS newsQ/C Technologies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VRAXVirax Biolabs Group Limited | 0.3319 | -12.89% | $446.40K | vs QCLS |
| CDIOCardio Diagnostics Holdings Inc. | 1.60 | -3.03% | $4.74M | vs QCLS |
| BMRABiomerica Inc. | 1.08 | -0.92% | $4.97M | vs QCLS |
| TRIBTrinity Biotech plc ADR | 6.24 | +13.76% | $5.07M | vs QCLS |
| VNRXVolitionRX Limited | 0.1621 | -1.58% | $5.85M | vs QCLS |
| IMDXInsight Molecular Diagnostics Inc. | 1.97 | +18.67% | $80.88M | vs QCLS |
| ICCCImmuCell Corporation | 10.92 | -2.41% | $99.28M | vs QCLS |
| NNNNAnbio Biotechnology Class A | 3.32 | -9.04% | $145.72M | vs QCLS |
Indexes, lists and sector
Q/C Technologies stock FAQ
What is Q/C Technologies's stock price today?
QCLS last traded at $0.2784 as of Nov 20, 4:00 PM EST, down 6.01% on the day. Prices are delayed at least 15 minutes.
What is QCLS's P/E ratio?
QCLS trades at a trailing P/E ratio of 0.06.
What is the QCLS 52-week high?
The 52-week high for QCLS is $8.17 and the 52-week low is $0.275. The stock is currently 96.6% below its high.